DSGN Shares Outstanding History Table | ||||||||||||||||||||||||||||
Also see: DSGN Market Cap History DSGN YTD Return |
DSGN Shares Outstanding History Table | ||||||||||||||||||||||||||||
Also see: DSGN Market Cap History DSGN YTD Return |
DSGN Shares Outstanding History Chart | |||||||||||||||||||||||||||||
+1.65% CAGR Mouse over chart for data details
|
DSGN Stock Price Chart |
About Design Therapeutics Inc |
Design Therapeutics is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTAC molecules. The U.S. Food and Drug Administration has granted Fast Track designation to Co.'s primary Friedreich ataxia (FA) GeneTAC development candidate (DT-216) for the treatment of patients with FA. Co.'s second GeneTAC development candidate (DT-168) is an eye drop for the treatment of Fuchs Endothelial Corneal Dystrophy. Co.'s third program based on the GeneTAC platform is myotonic dystrophy type-1. Co. continues to develop its GeneTAC portfolio in preclinical studies to address other serious nucleotide repeat expansion-driven monogenic diseases. We show 13 historical shares outstanding datapoints in our coverage of DSGN's shares outstanding history. Understanding the changing numbers of DSGN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DSGN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DSGN by allowing them to research DSGN shares outstanding history as well as any other stock in our coverage universe. |
DSGN Current Stock Quote |
Free DSGN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
DSGN Share Performance |
Shares Outstanding Peers |
Design Therapeutics (DSGN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
DTIL Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.